Plastic Healthcare Packaging Market : Global Industry Analysis and Opportunity Assessment, 2036

Plastic Healthcare Packaging Market Size, Market Forecast and Outlook By FMI

Plastic healthcare packaging market recorded a value of USD 80.9 billion in 2025 and is expected to reach USD 83.9 billion in 2026. Demand is projected to expand at a 3.7% CAGR between 2026 and 2036, taking the market to USD 120.6 billion by 2036. primary packaging is expected to account for 61.8% of packaging type demand in 2026 and conventional packaging is projected to lead technology with 58.7% share.

Summary of the Plastic Healthcare Packaging Market

• Demand and Growth Drivers
  • Medicine stability needs sustain demand for plastic healthcare packaging as drug makers protect filled products during storage.
  • Filling-line compatibility strengthens plastic pack use as bottles and blisters need repeatable sealing performance.
  • Regulated labeling needs reinforce demand for packs with reliable surfaces and traceable product information.
• Product and Segment View
  • Primary packaging is projected to account for 61.8% share in 2026 as direct product contact makes pack quality important to drug protection.
  • Conventional packaging is set to represent 58.7% of technology use in 2026 through its fit with high-volume standard drug lines.
  • Polyethylene is estimated to hold 38.4% material share in 2026 since bottles and closures need stable resin cost and processing control.
• Geography and Competitive Outlook
  • China is expected to record a CAGR of 4.8% through 2036 as healthcare output and medicine access expand.
  • India is projected to expand at 4.4% CAGR during the forecast period, as export-oriented pharmaceutical production needs reliable pack formats.
  • Companies combining healthcare-grade conversion with global supply reach are strengthening their position during the forecast period.
• Analyst Opinion
  • Ismail Sutaria, Principal Consultant for the Packaging domain at FMI, says, “Plastic healthcare packaging is becoming a quality control decision for pharmaceutical and device companies. Packaging teams need drug stability protection with smooth filling line performance. Resin-linked purchasing and validation work raise cost while material control reduces approval friction during qualification.”
• Plastic Healthcare Packaging Market Value Analysis
  • The plastic healthcare packaging market is moving from routine container supply into a regulated product-protection base.
  • Medicine stability requirements and direct-contact pack approval needs are rising use across pharmaceutical filling lines.
  • The market benefits from deeper use of pharmaceutical plastic packaging across branded and generic medicine programs.
  • Validation records and defined packaging specifications strengthen adoption by reducing handling errors during manufacturing and distribution.

Regulations like the FDA’s Drug Supply Chain Security Act (DSCSA) require tracking each package individually. As a result, packaging must have durable labels and readable codes that remain intact throughout distribution and recalls.

The FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, aligns with ISO 13485:2016 and increases documentation requirements for medical device packaging. Suppliers must now prove and document changes to packaging (like trays and sterile barriers) before approval. Material choices are also becoming more selective. For example, Amcor’s HDPE AmSky™ blister system offers a recyclable alternative to traditional PVC blisters, while still working with existing packaging processes.

Plastic Healthcare Packaging Market Definition

The plastic healthcare packaging market includes polymer-based packaging used to protect medicines and medical products before use. Packs serve oral solids, liquids, biologics, devices, and sterile medical items. Scope includes bottles, blisters, pouches, vials, ampoules, prefilled systems, closures, trays, and tubes. Finished medicines, finished devices, glass-only containers, and packaging machinery are outside the scope.

Plastic Healthcare Packaging Market Inclusions

Market scope covers all commercially traded plastic healthcare packaging products categorized by material type and product type. It covers application, packaging type, end use, and technology across pharmaceutical and medical device packaging. Product coverage includes bottles, blisters, vials, ampoules, pouches, prefilled systems, closures, trays, and medication tubes. Revenue scope covers 2026 to 2036. Key stakeholders include healthcare packaging manufacturers, resin suppliers, pharmaceutical companies, medical device firms, contract packaging organizations, distributors, hospitals, clinics, and regulatory bodies.

Plastic Healthcare Packaging Market Exclusions

Scope does not include finished pharmaceuticals, finished medical devices, glass-only packaging, metal-only containers, paper-only cartons, or packaging equipment.

Plastic Healthcare Packaging Market Research Methodology

• Primary Research: FMI analysts talked to pharmaceutical manufacturers, healthcare packaging converters, contract packers, and resin suppliers in important markets.
• Desk Research: Combined data from regulatory guidance, product portfolios, healthcare pack specifications, and company packaging coverage.
• Market sizing and forecasting: Added packaging use across product formats and application groups from the bottom up.
• Data validation: Cross-checked every three months against healthcare packaging demand patterns and company portfolio coverage.

Why is the Plastic Healthcare Packaging Market Growing?

• Pharmaceutical manufacturers are using direct-contact plastic packs to reduce filling loss and protect medicine stability.
• Device companies are using trays and sterile packs to protect medical products during hospital handling.
• Contract packaging organizations are using bottles and blisters as brand owners outsource pack finishing work.

Medicine launches are creating increasing the amount of work for formats that can protect sensitive products through approval and supply planning. According to FDA's January 2025 report, CDER approved 18 biosimilars for 8 reference products in 2024. Biosimilar supply often needs dependable containers and closure systems for regulated biologic handling. Packaging teams must qualify materials early so product stability and label readability are protected before launch. Suppliers with proven drug-contact plastic formats can reduce approval delays and help manufacturers manage scale-up risk.

Healthcare packaging demand also follows traceability pressure across medicine distribution. FDA’s Drug Supply Chain Security Act framework places package-level tracing at the center of prescription drug security. This raises the value of plastic packs with clean label areas and reliable code readability. Suppliers serving pharmaceutical packaging can gain when pack design helps customers avoid scanning and relabeling issues.

Market Segmentation Analysis

• Polyethylene is projected to represent 38.4% of material use in 2026, as bottle and closure producers favor its processing stability.
• Bottles are expected to capture 22.6% of product type revenue in 2026 through steady use in solid dose and liquid dose formats.
• Pharmaceutical applications are anticipated to hold 57.3% share in 2026, reflecting their central role in medicine packaging.
• Primary packaging is forecast to lead the packaging type segment with 61.8% share in 2026 through direct contact with filled products.
• Conventional packaging is projected to account for 58.7% of technology adoption in 2026, as standard barrier formats suit high-volume medicine lines.

The market for plastic healthcare packaging is divided into six primary segment groups based on material, product type, application, packaging type, end use, and technology. Materials include polyethylene, PVC, PS, PP, PET, and others. Product type includes bottles, vials and ampoules, blisters, bags, pouches and sachets, prefilled systems, containers and jars, caps and closures, trays, and medication tubes. Application includes pharmaceuticals and medical devices. End users include pharmaceutical manufacturers, contract packaging organizations, and healthcare providers.

Insights into Plastic Healthcare Packaging Market by Material

• In 2026, polyethylene is expected to make up 38.4% of the material segment. The resin serves bottles and closures that require stable molding performance across regulated medicine packs.
• Polypropylene and PET address selected rigid formats with higher clarity or strength needs. Their use improves in packaging programs requiring sharper presentation or stronger dimensional control.

Insights into Plastic Healthcare Packaging Market by Product Type

• Bottles are projected to hold 22.6% of the product type segment in 2026. Solid dose and liquid dose packaging programs use bottles for dependable filling and closure performance.
• Blisters and pouches address dose protection and smaller pack formats. Their value improves in medicine lines requiring portion control or moisture protection.

Insights into Plastic Healthcare Packaging Market by Application

• Pharmaceuticals are expected to account for 57.3% of the application segment in 2026. Drug manufacturers use plastic packs to protect oral solids and liquid formulations during storage.
• Medical device applications require trays and protective packs for diagnostic products. Their demand improves in hospital supply chains requiring sterile handling and damage prevention.

Insights into Plastic Healthcare Packaging Market by Packaging Type

• Primary packaging is estimated to hold 61.8% of the packaging type segment in 2026. Direct-contact formats carry higher value as medicine stability and contamination control guide pack approval.
• Secondary and tertiary packs protect labeled products during distribution. Their role improves when brand owners need better shipment control and organized hospital delivery.

Insights into Plastic Healthcare Packaging Market by Technology

• Conventional packaging is projected to represent 58.7% of the technology segment in 2026. Standard barrier formats serve high-volume medicine lines and standard lines rely on familiar filling systems for efficient large-scale production.
• Advanced packaging serves traceability and anti-counterfeiting needs across regulated channels. Its role improves when drug makers need readable codes and stronger product authentication.

Plastic Healthcare Packaging Market Drivers, Restraints, and Opportunities

• Primary pack qualification is creating structured demand for resin records and seal validation across drug programs.
• Resin price exposure creates margin pressure for converters serving cost-sensitive pharmaceutical packaging contracts.
• Traceable pack formats create opportunity through readable labels and tamper-evident closure designs.

Plastic healthcare packaging keeps expanding because drug manufacturers and device companies need stable packs to protect filled products. Resin cost pressure and pack qualification work can slow broader use across price-sensitive medicine programs. Demand advances through primary packaging formats and conventional barrier packs used in high-volume pharmaceutical lines.

Resin Benchmarks Are Tightening Quote Discipline

Plastic healthcare packaging buyers are treating resin costs as a clearer part of supplier quotations. Resin pressure is most visible in sterile barrier packs and rigid formats such as bottles and closures. It affects trays and pouches used in diagnostic consumable packaging. In December 2025, Pew reported that, as of spring 2025, traded polyethylene and polypropylene prices were roughly US$1,000 per metric ton, while PET was about USD 1,200 per metric ton. For healthcare packaging, this is important as converters cannot easily down-gauge or switch polymers without validation and sterilization compatibility requirements. Converters must address regulatory review processes before implementing any material changes across approved drug packaging formats. Sourcing teams should separate resin-related escalation clauses from conversion and cleanroom charges during supplier negotiations.

Oil Volatility Is Repricing Polymer Risk

Crude-linked volatility is affecting plastic healthcare packaging negotiations, particularly where suppliers use petroleum-derived PE, PP, PET, PVC, or specialty films. In May 2026, the U.S. Energy Information Administration reported Brent crude averaged US$117 per barrel in April 2026 after reaching US$138 per barrel on April 7, with prices expected around US$106 per barrel in May and June as inventories fall by 8.5 million barrels per day in Q2 2026. For medical and pharmaceutical packaging buyers, the implication is higher resin exposure, shorter quote validity, tighter pass-through language, and greater need for dual-sourcing resin grades approved for healthcare applications.

Analysis of Plastic Healthcare Packaging Market By Key Countries

Country	CAGR
China	4.8%
India	4.4%
Germany	4.1%
Brazil	3.7%
USA	3.3%
UK	3.0%
Japan	2.6%

Source: Future Market Insights, 2026.

Plastic Healthcare Packaging Market CAGR Analysis By Country

• China is projected to lead with a 4.8% CAGR to 2036 as broader healthcare access raises medicine packaging requirements.
• India is expected to expand at 4.4% CAGR during the forecast period as export-oriented drug production increases validated pack needs.
• Germany is forecast to advance at 4.1% CAGR by 2036 as established pharmaceutical output keeps primary pack qualification important.
• Brazil is projected to record 3.7% CAGR across the assessment period as public medicine programs add insulin packaging demand.
• USA is forecast at 3.3% CAGR between 2026 and 2036 as product approvals maintain compliant packaging needs.
• Demand in the UK is predicted to post 3.0% CAGR over the forecast years as life sciences manufacturing favors controlled packaging quality.
• Japan is projected to expand at 2.6% CAGR by the end of 2036 as mature medicine channels limit volume acceleration.

Demand for plastic healthcare packaging is forecast to rise at 3.7% CAGR from 2026 to 2036. Country-level analysis covers the major markets contributing to this forecast, with the key markets listed below.

Demand Outlook for Plastic Healthcare Packaging Market in China

Plastic healthcare packaging industry in China is projected to record a CAGR of 4.8% through 2036. China maintained basic medical insurance coverage near 95% during 2021 to 2025, with over 1.32 billion people enrolled in 2024. This large access base sustains demand for medicine packs across retail and hospital channels. Local converters can gain from drug makers who need compliant labels and medical packaging formats.

• Healthcare coverage scale sustains demand for repeat-use medicine packaging and standard primary packs.
• Pharmaceutical retail policy reform supports pack traceability and compliant labeling across medicine distribution.
• Local producers need plastic packaging suppliers that can handle volume and documentation together.

Sales Analysis of Plastic Healthcare Packaging Market in India

Plastic healthcare packaging sector in India is expected to expand at a CAGR of 4.4% during the assessment period. Pharmaceutical exports stood at USD 30.5 billion in 2024-25 and reached 191 countries. Medical device exports increased from USD 2.5 billion in FY21 to USD 4.1 billion in FY25. Export exposure raises the need for packs to meet regulated buyer expectations. [1]

• Export medicine programs need bottles and blisters with reliable barrier performance.
• Medical device export expansion increases demand for trays and sterile protective packs.
• Contract packers need suppliers who reduce rework across labeling and pack finishing.

Demand Outlook for Plastic Healthcare Packaging Market in Germany

Germany plastic healthcare packaging sector is forecast to grow at a CAGR of 4.1% by 2036. Pharmaceutical output can be uneven, as Destatis reported a 17.7% month-on-month fall in pharmaceutical production in April 2025 after seasonal adjustment. Such volatility raises the value of suppliers with flexible production planning. Healthcare converters serving Germany need consistent quality and shorter response cycles.

• Mature pharmaceutical production keeps demand focused on pack reliability and production planning.
• Primary packaging suppliers need strong change-control records for regulated medicine customers.
• Blister and bottle demand benefits from established drug manufacturing and hospital supply channels.

Opportunity Analysis of Plastic Healthcare Packaging Market in Brazil

The plastic healthcare packaging segment in Brazil is forecast to advance at 3.7% CAGR over the forecast years. Brazil resumed domestic insulin activity through a public health program with an initial plan to produce 20 million vials of insulin glargine for SUS supply. The program supports demand for compliant vial systems and secondary protection. Local healthcare packaging suppliers gain when public medicine programs require dependable pack availability.

• Public medicine programs create steady demand for vials and direct-contact packaging formats.
• Local insulin supply needs reliable closure systems and shipment-ready secondary packs.
• Domestic health programs support suppliers that can meet volume needs without quality variation.

Future Outlook for Plastic Healthcare Packaging Market in the United States

The U.S. plastic healthcare packaging industry is expected to post 3.3% CAGR oevr the assessment period. FDA’s CDER approved 46 novel drugs in 2025. New drug activity adds packaging work across container selection and stability testing during development and validation phases. It increases responsibilities related to label design as teams align artwork with regulatory and commercial requirements. These added tasks expand coordination efforts across packaging functions and increase timelines and resource planning needs. Saturated U.S. demand favors suppliers with high documentation strength and dependable medical device packaging portfolios.

• FDA-facing drug programs need packaging suppliers with clear material and closure records.
• Injectable and specialty drugs increase demand for small-format packs with tighter quality control.
• Established sourcing groups compare pack cost against recall exposure and launch timing risk.

Demand Outlook for Plastic Healthcare Packaging Market in the UK

The UK plastic healthcare packaging industry is expected to expand at 3.0% CAGR by 2036. UK pharmaceutical R&D performed by businesses reached GBP 9.3 billion in 2024 and accounted for 17% of total business R&D expenditure. This activity keeps packaging demand connected to drug development and medicine launch planning. Suppliers with smaller-batch flexibility can serve clinical and commercial packaging work.

• Life sciences R&D activity raises demand for trial packs and early commercial packaging.
• Mature healthcare channels help suppliers with documentation and reliable delivery records.
• UK buyers value pack consistency across small batches and regular medicine supply programs.

In-depth Analysis of Plastic Healthcare Packaging Market in Japan

Plastic healthcare packaging industry in Japan is forecast at 2.6% CAGR through 2036. PMDA’s approved-products page lists new drug approval information through September 2025. Mature medicine access and strict documentation practices keep packaging demand disciplined. Suppliers serving Japan need strong quality records and controlled format changes. [2]

• Mature drug channels keep plastic pack demand steady across bottles and blister formats.
• Older patient needs sustain demand for clear labeling and easy handling features.
• Packaging suppliers need careful documentation as Japanese buyers value process stability.

Competitive Landscape and Strategic Positioning

• Competition in plastic healthcare packaging is focused on regulated pack reliability and access to global pharmaceutical customers.
• Amcor Limited leads through broad healthcare packaging coverage and customer access across drug packaging programs.
• Gerresheimer AG and Schott AG use high-control containers and drug-contact packaging strength.
• Specialist providers serve blisters and closures for regulated healthcare applications requiring focused format knowledge.

Amcor Limited holds a significant position through broad plastic healthcare packaging coverage across multiple product formats. Berry Global, Inc. adds scale across rigid and flexible plastic packaging used by pharmaceutical customers. Gerresheimer AG and Schott AG focus on controlled drug-contact containers and proven packaging quality. Klockner Pentaplast Group strengthens the competitive field through film capability for blister and thermoforming applications.[3][4]

Resin cost exposure and strict customer qualification create entry barriers across regulated drug packaging. Material control and faster documentation are becoming priorities across long product approval cycles. Pharmaceutical manufacturers favor suppliers offering primary pack quality and stable supply with less filing uncertainty. Companies with broad healthcare portfolios and dependable documentation can win longer packaging programs.

Key Companies in the Plastic Healthcare Packaging Market

Key global companies leading the plastic healthcare packaging market include:

• Amcor Limited, Berry Global, Inc., and Gerresheimer AG have established packaging infrastructure for primary and secondary healthcare formats.
• Schott AG, West Pharmaceutical Services, Inc., and Aptar Group, Inc. serve manufacturers through drug-contact packaging and delivery-adjacent components.
• Bilcare Limited, Klockner Pentaplast Group, and Comar LLC hold specialist positions across blister films and healthcare containers.

Competitive Benchmarking: Plastic Healthcare Packaging Market

Company	Healthcare Material Breadth	Primary Pack Validation Depth	Global Supply Reach	Geographic Footprint
Amcor Limited	High	High	Strong	Global coverage across North America, Europe, Asia Pacific, and Latin America
Berry Global, Inc.	High	Medium	Strong	Legacy global footprint now under Amcor after the completed 2025 combination
Gerresheimer AG	High	High	Strong	Production sites and locations across 16 countries on three continents
Schott AG	Medium	High	Strong	SCHOTT Pharma operates across North America, Europe, Asia, and Latin America
Klockner Pentaplast Group	High	High	Strong	Global film network with customer service and technical support in more than 60 countries
West Pharmaceutical Services, Inc.	Medium	High	Strong	Americas, Europe, and Asia Pacific
Aptar Group, Inc.	Medium	High	Strong	Manufacturing and sales locations across 20 countries
Bilcare Limited	Medium	Medium	Moderate	India-led base with customer reach across global pharmaceutical packaging markets
Comar LLC	Medium	Medium	Moderate	United States, Puerto Rico, and Ireland
Adelphi Healthcare Packaging	Medium	High	Moderate	UK-based supplier with global pharmaceutical packaging distribution reach

Source: Future Market Insights, 2026.

Key Developments in Plastic Healthcare Packaging Market

• In June 2025, Sanner started manufacturing in Greensboro for injection molded medical device components and pharmaceutical packaging.
• In January 2026, TekniPlex Healthcare announced expanded multidose packaging capabilities and advanced barrier materials for pharmaceutical applications at Pharmapack.

Key Players in the Plastic Healthcare Packaging Market

Major Global Players:

• Amcor Limited
• Gerresheimer AG
• Schott AG
• Klockner Pentaplast Group
• Berry Global, Inc.
• West Pharmaceutical Services, Inc.
• Aptar Group, Inc.

Specialist Players:

• Bilcare Limited
• Comar LLC
• Nipro Corporation
• Adelphi Healthcare Packaging
• Wipak Ltd.
• Mondi Group plc

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 83.9 billion to USD 120.6 billion, at a CAGR of 3.7%
Market Definition	Plastic healthcare packaging includes polymer-based packs used to protect medicines and medical products before use.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	USA, UK, Germany, China, India, Japan, South Korea, Brazil, and 30 plus countries
Key Companies Profiled	Amcor Limited, Berry Global, Inc., Gerresheimer AG, Schott AG, Klockner Pentaplast Group, West Pharmaceutical Services, Inc., Aptar Group, Inc., Bilcare Limited, Comar LLC, Adelphi Healthcare Packaging
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with pack demand and validated segment use patterns.[5]

Plastic Healthcare Packaging Market by Segments

Plastic Healthcare Packaging Market Segmented by Material:

• Polyethylene
  • High Density Polyethylene
  • Low Density Polyethylene
  • Linear Low Density Polyethylene
• Polyvinyl Chloride
  • Rigid PVC
  • Flexible PVC
• Polystyrene
  • General Purpose Polystyrene
  • High Impact Polystyrene
• Polypropylene
  • Homopolymer PP
  • Copolymer PP
• Polyethylene Terephthalate
  • Amorphous PET
  • Crystalline PET
• Others
  • Polycarbonate
  • Bioplastics

Plastic Healthcare Packaging Market Segmented by Product Type:

• Bottles
  • Solid Dose Bottles
  • Liquid Dose Bottles
• Vials and Ampoules
  • Glass Vials
  • Plastic Ampoules
• Blisters
  • Cold Form Blisters
  • Thermoform Blisters
• Bags
  • IV Bags
  • Blood Bags
• Pouches and Sachets
  • Single Dose Sachets
  • Multi Dose Pouches
• Prefilled Systems
  • Prefilled Syringes
  • Cartridge Systems
• Containers and Jars
  • Wide Mouth Containers
• Caps and Closures
  • Child Resistant Closures
  • Screw Caps
• Trays
  • Medical Procedure Trays
• Medication Tubes
  • Ointment Tubes
  • Cream Tubes

Plastic Healthcare Packaging Market Segmented by Application:

• Pharmaceuticals
  • Solid Dosage Forms
  • Liquid Dosage Forms
  • Biologics
• Medical Devices
  • Diagnostic Devices
  • Surgical Devices

Plastic Healthcare Packaging Market Segmented by Packaging Type:

• Primary Packaging
  • Blister Packs
  • Bottles and Vials
  • Prefilled Systems
• Secondary Packaging
  • Cartons
  • Labels and Leaflets
• Tertiary Packaging
  • Bulk Transport Packaging

Plastic Healthcare Packaging Market Segmented by End Use:

• Pharmaceutical Manufacturers
  • Generic Drug Manufacturers
  • Branded Drug Manufacturers
• Contract Packaging Organizations
  • Outsourced Packaging Services
• Healthcare Providers
  • Hospitals
  • Clinics

Plastic Healthcare Packaging Market Segmented by Technology:

• Conventional Packaging
  • Standard Barrier Packaging
  • Basic Plastic Packaging
• Advanced Packaging
  • Smart Packaging
  • Track and Trace Systems
  • Anti Counterfeiting Solutions

Plastic Healthcare Packaging Market by Region:

• North America
  • U.S.
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Rest of Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Saudi Arabia
  • Other GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Research Sources and Bibliography

1. The Pew Charitable Trusts. (2025, December 3). Breaking the Plastic Wave 2025.
2. USA Energy Information Administration. (2026, May 12). Short-Term Energy Outlook.
3. USA Food and Drug Administration. (2026, May). Novel drug approvals for 2025. FDA.
4. Press Information Bureau. (2026, March). India’s pharmaceuticals in global healthcare. Government of India.
5. State Council of the People’s Republic of China. (2025, July). Broader, improved medical coverage for a healthier country.
6. Federal Statistical Office of Germany. (2025, June). Production in April 2025: -1.4% on the previous month. Destatis.
7. Ministério da Saúde. (2025, July). Após 20 anos, Brasil retoma produção de insulina em iniciativa conduzida pelo Ministério da Saúde. Government of Brazil.
8. Ministério da Saúde. (2025, November). Ministro da Saúde recebe 2,1 milhões de unidades de insulina glargina produzidas com tecnologia nacional. Government of Brazil.
9. Department for Science, Innovation and Technology. (2026, March). Life sciences competitiveness indicators 2026: Summary. GOV.UK.
10. Pharmaceuticals and Medical Devices Agency. (2025, September). List of approved products. PMDA.

This Report Answers

• What is the current and future size of the plastic healthcare packaging market?
• How fast is the plastic healthcare packaging market expected to expand between 2026 and 2036?
• Which packaging type is expected to lead the market by 2026?
• Which material segment is expected to account for the most demand by 2026?
• What factors are driving demand for plastic healthcare packaging globally?
• How are traceability needs influencing adoption of qualified healthcare packaging?
• Why are pharmaceutical manufacturers the main demand base for plastic healthcare packaging?
• How are drug approvals creating demand for primary packaging validation?
• Which countries are projected to record faster expansion through 2036?
• What is driving market expansion in China and India?
• Who are the key companies active in the plastic healthcare packaging market?
• How does FMI estimate and validate the market forecast?